125 related articles for article (PubMed ID: 2524601)
1. Deoxyribonucleic acid content and medroxyprogesterone acetate treatment in metastatic renal cell carcinoma.
Ljungberg B; Tomić R; Roos G
J Urol; 1989 Jun; 141(6):1308-10. PubMed ID: 2524601
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma.
Ljungberg B; Stenling R; Roos G
J Urol; 1986 Oct; 136(4):801-4. PubMed ID: 3761435
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma.
Chin JL; Pontes JE; Frankfurt OS
J Urol; 1985 Apr; 133(4):582-5. PubMed ID: 3981703
[TBL] [Abstract][Full Text] [Related]
4. Re: Deoxyribonucleic acid content and medroxyprogesterone acetate treatment in metastatic renal cell carcinoma.
Neuwirth H; Blyth B; Richie AW; Taube DM; deKernion JB
J Urol; 1990 Sep; 144(3):749-50. PubMed ID: 2143789
[No Abstract] [Full Text] [Related]
5. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
6. Deoxyribonucleic acid content in metastatic renal cell carcinoma: clinical implications.
Ljungberg B; Roos G; Stenling R
Semin Surg Oncol; 1988; 4(3):165-8. PubMed ID: 3187294
[TBL] [Abstract][Full Text] [Related]
7. Tumor spread and DNA content in human renal cell carcinoma.
Ljungberg B; Stenling R; Roos G
Cancer Res; 1988 Jun; 48(11):3165-7. PubMed ID: 3365699
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the DNA content of renal carcinoma.
deKernion JB; Mukamel E; Ritchie AW; Blyth B; Hannah J; Bohman R
Cancer; 1989 Oct; 64(8):1669-73. PubMed ID: 2790681
[TBL] [Abstract][Full Text] [Related]
11. Characterization of conservatively resected renal tumors using automated image analysis DNA cytometry.
Stöckle M; Störkel S; Mielke R; Steinbach F; el-Damanhoury H; Voges G; Hohenfellner R
Cancer; 1991 Nov; 68(9):1926-31. PubMed ID: 1717131
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the 1 alpha, 25-dihydroxyvitamin D3 receptor concentration and the DNA content in renal cell carcinomas.
Trydal T; Bakke A; Aksnes L; Aarskog D
Anticancer Res; 1989; 9(6):1951-5. PubMed ID: 2560627
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic and flow cytometric DNA analysis in renal cell carcinoma.
Ljungberg B; Nordenson I; Roos G
Eur Urol; 1991; 19(1):59-64. PubMed ID: 2007420
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA ploidy, cell cycle and cytomorphometry in sarcomatoid renal cell carcinoma.
Yu DS; Wang J; Chang SY; Ma CP
Eur Urol; 1991; 20(3):227-31. PubMed ID: 1823046
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features.
Nakano E; Kondoh M; Okatani K; Seguchi T; Sugao H
Cancer; 1993 Aug; 72(4):1319-23. PubMed ID: 8339220
[TBL] [Abstract][Full Text] [Related]
16. [Tumor heterogeneity of renal cell carcinoma as analyzed by flow cytometry].
Nagamori S
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):593-600. PubMed ID: 2374332
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study.
Pizzocaro G; Piva L; Di Fronzo G; Giongo A; Cozzoli A; Dormia E; Minervini S; Zanollo A; Fontanella U; Longo G
J Urol; 1987 Dec; 138(6):1379-81. PubMed ID: 2824861
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells.
Kushima M; Kushima R; Hattori T; Tomoyoshi T
Urol Res; 1995; 23(6):381-6. PubMed ID: 8788276
[TBL] [Abstract][Full Text] [Related]
19. In vivo aneuploidization during the expansion of renal adenocarcinoma.
Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous renal and transitional cell carcinomas in same kidney with subsequent lymph node metastasis: DNA flow cytometric study.
el-Naggar A; Ro JY; Sella A; Ayala AG
Urology; 1991 Dec; 38(6):585-8. PubMed ID: 1746094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
